OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024
Felicia Cosman, E. Michael Lewiecki, Richard Eastell, et al.
Journal of Bone and Mineral Research (2024) Vol. 39, Iss. 10, pp. 1393-1405
Open Access | Times Cited: 11

Showing 11 citing articles:

Probability of Achieving Bone Mineral Density Treatment Goals with Denosumab Treatment in Postmenopausal Women with Osteoporosis
Felicia Cosman, Zhenxun Wang, Xiaodong Li, et al.
Journal of Bone and Mineral Research (2025)
Closed Access

Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approach
Olivier Lamy, Judith Everts‐Graber, Elena González Rodríguez
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access

Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study
Kyoung Jin Kim, Kyoung Min Kim, Young‐Kyun Lee, et al.
Journal of Bone Metabolism (2025) Vol. 32, Iss. 1, pp. 57-66
Closed Access

Sequential and Long-term Therapy for Osteoporosis
Michael R. McClung
Current Osteoporosis Reports (2025) Vol. 23, Iss. 1
Closed Access

Gusongan capsule enhances osteogenic differentiation to mitigate bone loss in ovariectomized rats via the TLR2/NF-κB pathway
Lingfeng Zeng, Jinlong Zhao, Zhuoxu Gu, et al.
Phytomedicine (2025), pp. 156705-156705
Closed Access

An update on the pharmacotherapy of osteoporosis
A. N. Shashidhara, Syed Haider Tahir, Zain Abbas, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access

First‐line treatment of osteoporosis with osteoanabolic therapy: a new opportunity
Jasna Aleksova, Peter R. Ebeling
Internal Medicine Journal (2025)
Open Access

Romosozumab for the treatment of osteoporosis – a systematic review
Vivi-Nelli Mäkinen, Anne Sophie Sølling, Michael R. McClung, et al.
Journal of Endocrinological Investigation (2024)
Closed Access | Times Cited: 2

TRIM65 Promotes Osteogenic Differentiation by Regulating the PI3K/AKT Signaling Pathway
Hong-Pu Li, Tingting Zeng, Zhi‐Xiang Zhou, et al.
Open Medicine Journal (2024) Vol. 11, Iss. 1
Open Access

Osteoporosis treatment: Bone-forming agents
Bente Langdahl, Vivi-Nelli Mäkinen, Anne Sophie Sølling
Elsevier eBooks (2024)
Closed Access

Assessment of trabecular bone score (TBS) in the prediction of vertebral fracture in postmenopausal osteoporosis
Federica Biamonte, Jessica Pepe, Luciano Colangelo, et al.
Bone (2024) Vol. 190, pp. 117307-117307
Closed Access

Eficacia y seguridad del tratamiento de la osteoporosis en el anciano. Propuesta de SEFRAOS para abordaje de la prevención secundaria de fracturas en el adulto mayor
Jessie D. Trujillo, Bernardo Abel Cedeño‐Veloz
Revista Española de Geriatría y Gerontología (2024) Vol. 60, Iss. 3, pp. 101611-101611
Closed Access

Proceedings of the 2024 Santa Fe Bone Symposium: Update on the Management of Osteoporosis and Rare Bone Diseases
E. Michael Lewiecki, John P. Bilezikian, Amanda Clark, et al.
Journal of Clinical Densitometry (2024) Vol. 28, Iss. 1, pp. 101559-101559
Open Access

Page 1

Scroll to top